Saidal Group has supplied the Central Pharmacy of Hospitals with over 25 strategic therapeutic products since early 2026, totaling more than 25 billion Algerian dinars. Narjes Berichi, Director of Marketing and Sales, stated that this initiative is part of a national strategy to lower import costs and ensure the availability of vital medications. The group is launching raw material production projects in the provinces of Batna, Médéa, Sétif, and Mostaganem, focusing on antibiotics, diabetes treatments, and oncology drugs. Additionally, a new unit for diagnostic reagents has been established in Oran. With international partnerships involving global firms like Roche and Novo Nordisk, Saidal is maintaining high manufacturing standards while actively pursuing export opportunities in the African market.